Extracorporeal modification of plasma and whole blood.
D000230:Adenocarcinoma / Q000628:therapy / Q000662:veterinary; D000818:Animals; D001215:Asparaginase / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D005112:Extracorporeal Circulation; D006464:Hemoperfusion / Q000379:methods; D006801:Humans; D007163:Immunosorbent Techniques; D016030:Kidney Transplantation; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000628:therapy / Q000662:veterinary; D008223:Lymphoma / Q000628:therapy / Q000662:veterinary; D008297:Male; D008321:Mammary Glands, Animal; D009369:Neoplasms / Q000628:therapy / Q000662:veterinary; D010949:Plasma; D013205:Staphylococcal Protein A / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000276:immunology
D008077:Lipoproteins, LDL; D013205:Staphylococcal Protein A; D001215:Asparaginase